SUBSCRIBE
SUBSCRIBE
News   Deals

GlaxoSmithKline CEO Sees More Bolt-on Acquisitions in 2009

January 9, 2009 | 
1 min read
NEW YORK/LONDON, Jan 8 (Reuters) - GlaxoSmithKline expects to make further acquisitions in 2009 to bolster its business in emerging markets and in selling over-the-counter medicines, its chief executive said on Thursday.
Mergers & acquisitions
GlaxoSmithKline
MORE ON THIS TOPIC
Glowing red up arrow surrounded by dollar signs in black background. Illustration of the concept of positive return on investment and business earnings
IPO
Neuroscience Biotech LB Files for $228M IPO To Support Phase III Plans
September 9, 2025
 · 
1 min read
 · 
Annalee Armstrong
Marburg, Germany - July 6, 2013: Marburg Office of Swiss multinational company Novartis AG
Mergers & acquisitions
Novartis Deals in Cardio Again, Dropping $1.4B To Acquire Tourmaline
September 9, 2025
 · 
2 min read
 · 
Tristan Manalac
Concept of saving money with a pink colored piggy bank held in a hand in front of a blackboard with hand drawn coins
Neuroscience
Servier Bets $450M On Kaerus’ Fragile X Syndrome Therapy
September 8, 2025
 · 
2 min read
 · 
Tristan Manalac
Changing or transforming, turning around, challenging the odds and conquering adversity, a businessman pole vaulting from the down arrow to the up arrow of growth
IPO
SPACs Line Up To Clear Biotech’s IPO Backlog
September 3, 2025
 · 
6 min read
 · 
Annalee Armstrong